5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Liver Cirrhosis in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| den Hartog, GJ | 1 |
| Qi, S | 1 |
| van Tilburg, JH | 1 |
| Koek, GH | 1 |
| Bast, A | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Liver Cirrhosis
| Article | Year |
|---|---|
Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: a new target in liver fibrosis.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Actins; Cell Line; Chloride Channels; Glycolates; | 2014 |